While P-gp remains a significant barrier for certain drugs and treatment strategies, the development of these alternative and combinatorial strategies has significantly improved remission rates and overall survival in many hematological cancers. The gene discussed is PGP; the disease is hematopoietic and lymphoid cell neoplasm.